Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 18 Sept 2024 for G1 Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleAndrew Perry
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Andrew Perry: trading record in brief
All filings by Andrew Perry on record concern G1 Therapeutics, Inc., in the capacity of senior executive. In total, 9 filings cover trades dated from 3 January 2022 to 18 September 2024.
No open-market purchase appears, only 3 sales worth €40k. Outside the open market, there are 6 share grants. Since January 2024: no purchases and 2 sales on the market.
On 18 September 2024 came the latest disclosure, a share grant in G1 Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Andrew Perry
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
16,100 sharesCommon StockSEC:0000950170-24-107787:0
1,337 shares@ US$2.50777.7% of flowCommon StockSEC:0001562180-24-005660:0
35,000 shares0Common StockSEC:0001562180-24-005608:0
8,151 shares@ US$4.788890.3% of flowCommon StockSEC:0001562180-24-004064:0
33,570 shares0Common StockSEC:0001562180-24-000325:0
355 shares@ US$2.45372.0% of flowCommon StockSEC:0001562180-23-005819:0
35,000 shares0Common StockSEC:0001562180-23-004095:0
16,100 shares0Common StockSEC:0001562180-23-000253:0
6,000 shares0Common StockSEC:0001562180-22-000308:0
9 of 9 declarations
